Evidence map›Paper›PMID 38675165›Full record

ArticlePharmaceutics2024

Exploring Microemulsion Systems for the Incorporation of Glucocorticoids into Bacterial Cellulose: A Novel Approach for Anti-Inflammatory Wound Dressings.

Paul Zahel, Vera Bruggink, Juliana Hülsmann, Frank Steiniger, Robert K Hofstetter, Thorsten Heinzel, Uwe Beekmann, Oliver Werz, Dana Kralisch

Open access · goldAbstract read
In one paragraph

Article in Pharmaceutics, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
1.0field-weighted citation impact, top 23% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed, 4 citations in OpenAlex.

  1. Article
  2. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 2 institutions in 1 country.

Paul ZahelJeNaCell GmbH-An Evonik Company, 07745 Jena, Germany.ORCID 0000-0002-0455-6044
Vera BrugginkJeNaCell GmbH-An Evonik Company, 07745 Jena, Germany.
Juliana HülsmannInstitute of Biochemistry and Biophysics, Center for Molecular Biomedicine, Friedrich Schiller University, 07745 Jena, Germany.ORCID 0009-0005-9754-4956
Frank SteinigerElectron Microscopy Center, University Hospital Jena, Friedrich Schiller University, 07743 Jena, Germany.ORCID 0009-0001-4347-6178
Robert K HofstetterDepartment of Pharmaceutical/Medicinal Chemistry, Institute of Pharmacy, Friedrich Schiller University, 07743 Jena, Germany.ORCID 0000-0002-1077-9703
Thorsten HeinzelInstitute of Biochemistry and Biophysics, Center for Molecular Biomedicine, Friedrich Schiller University, 07745 Jena, Germany.
Uwe BeekmannJeNaCell GmbH-An Evonik Company, 07745 Jena, Germany.ORCID 0000-0002-9839-5527
Oliver WerzDepartment of Pharmaceutical/Medicinal Chemistry, Institute of Pharmacy, Friedrich Schiller University, 07743 Jena, Germany.ORCID 0000-0002-5064-4379
Dana KralischJeNaCell GmbH-An Evonik Company, 07745 Jena, Germany.
Friedrich Schiller University Jena · DEEvonik (Germany) · DE

Funding

Deutsche Forschungsgemeinschaft 316213987 - SFB 1278 (project A02)European Union's Horizon 2020 research and innovation program under the Marie Skłodow-ska-Curie grant agreement 955335Free State of Thuringia and European Social Fund INP0046
6 · The paper itself

Abstract

The effective pharmacological treatment of inflamed wounds such as pyoderma gangraenosum remains challenging, as the systemic application of suitable drugs such as glucocorticoids is compromised by severe side effects and the inherent difficulties of wounds as drug targets. Furthermore, conventional semi-solid formulations are not suitable for direct application to open wounds. Thus, the treatment of inflamed wounds could considerably benefit from the development of active wound dressings for the topical administration of anti-inflammatory drugs. Although bacterial cellulose appears to be an ideal candidate for this purpose due to its known suitability for advanced wound care and as a drug delivery system, the incorporation of poorly water-soluble compounds into the hydrophilic material still poses a problem. The use of microemulsions could solve that open issue. The present study therefore explores their use as a novel approach to incorporate poorly water-soluble glucocorticoids into bacterial cellulose. Five microemulsion formulations were loaded with hydrocortisone or dexamethasone and characterized in detail, demonstrating their regular microstructure, biocompatibility and shelf-life stability. Bacterial cellulose was successfully loaded with the formulations as confirmed by transmission electron microscopy and surprisingly showed homogenous incorporation, even of w/o type microemulsions. High and controllable drug permeation through Strat-M

Indexed as

anti-inflammatorybacterial cellulosedexamethasonedrug deliveryglucocorticoidshydrocortisonemicroemulsionpyoderma gangraenosumwound carewound dressing

Identifiers

PMID38675165
PMCPMC11054342
OpenAlexW4394579338

What Socratic holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.